Omnipod DASH Security
from Business Wire
Insulet’s Omnipod DASH™ Insulin Management System Receives ISO 27001 Certification for Information Security
The Only Insulin Pump to Receive Both ISO 27001 and DTSec Certifications
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced it has received ISO (International Standards Organization) 27001 certification of its Omnipod DASH™ System. ISO 27001 certification is the international standard for best practice in an information security management system globally. Insulet also recently announced that the Company received the DTSec (Diabetes Technology Society’s) Cybersecurity Standard for Connected Diabetes Device Security certification for the Omnipod DASH System. Insulet is the only insulin pump company to receive both certifications.
ISO 27001 is an internationally recognized standard for information security best practice that adheres to the highest international data security standards. DTSec leverages ISO/IEC 15408 to provide a framework for risk-based, multi-stakeholder definition of security requirements. The Omnipod DASH System, Insulet’s next-generation platform, was designed to be the foundation for the Company’s future innovation. With the ISO 27001 and DTSec certifications, the Omnipod DASH System is now globally recognized for incorporating the highest standards for information and cyber security and safety, including secure data transfer between the Pod and the personal diabetes manager (PDM), as well as secure cloud storage.
“This is part of a large-scale organizational commitment to ensure the highest-level of cyber security of our Omnipod DASH System and to provide information security our Podders can trust,” said Dr. Aiman Abdel-Malek, Executive Vice President and Chief Technology Officer. “We are committed to remaining at the forefront of best-in-class standards to secure patients’ safety and privacy. Our compliance with these internationally recognized standards sets us apart from others in the global insulin pump market and provides our users with further peace of mind that they can rely on a highly safe and secure product to manage their diabetes.”
Insulet’s Omnipod DASH System received FDA clearance in June 2018 and is currently in limited market commercial release. The Company expects to fully launch the product commercially in early 2019.
Try a free no obligation demo of the Omnipod today!
Contour Next One App
The Contour Diabetes app now integrates with Apple Health. Once you enabled the feature, data from the Contour app will be available in the Blood Glucose area of your iOS Health app.
This is the meter that Omnipod users will be receiving when the DASH PDM is released sometime in the first quarter of 2019. Arden is using it now and we are finding the accuracy to be terrific!
Omnipod of the Future Revealed
Omnipod had a shareholder meeting this week and the slideshow that accompanied it was full of interesting stuff...
Timeline for new products and innovation
Exciting!
Relationship with Lilly to bring concentrated insulin
Looks like concentrated insulin keeps form factor small while adding enough insulin for people with greater needs...
New Bluetooth PDM and an Artificial Pancreas
Looks like the plan is to first release the Dash (new PDM) followed by the Horizon Artificial Pancreas system...
The entire slide deck can be found here, it has lots more info and business type stuff. I only brought you the exciting diabetes tech images. I need to get an Omnipod representative back on the Juicebox podcast. Good times ahead folks, good times! Lots of questions...